Transient repolarization instability following the initiation of cardiac resynchronization therapy

Europace

Volumn 13, Issue 9, 2011, Pages 1327-1334

  Braunschweig, Frieder ^a   Pfizenmayer, Hannes ^a   Rubulis, Aigars ^a   Schoels, Wolfgang ^b   Linde, Cecilia ^a   Bergfeldt, Lennart ^c  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b Department of Cardiology   (Germany)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Cardiac resynchronization therapy; Heart rate; Pro arrhythmia; Repolarization; Vectorcardiography

Indexed keywords

AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; SPIRONOLACTONE; WARFARIN;

ADULT; AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; BLOOD SAMPLING; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL ARTICLE; CLINICAL PROTOCOL; DOPPLER ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; HEART ARRHYTHMIA; HEART ELECTROPHYSIOLOGY; HEART RATE; HEART REPOLARIZATION; HUMAN; IMAGING SYSTEM; MALE; MINNESOTA LIVING WITH HEART FAILURE QUESTIONNAIRE; PRIORITY JOURNAL; QT INTERVAL; QUALITY OF LIFE; QUESTIONNAIRE; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT RESPONSE; TREATMENT WITHDRAWAL; VECTORCARDIOGRAPHY;

AGED; CARDIAC RESYNCHRONIZATION THERAPY; ELECTROCARDIOGRAPHY; HEART; HEART CONDUCTION SYSTEM; HEART FAILURE; HEART RATE; HEART VENTRICLES; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; TREATMENT OUTCOME; WALKING;

EID: 80052255732     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eur103     Document Type: Article

References (42)

1. St John Sutton M, Ghio S, Plappert T, Tavazzi L, Scelsi L, Daubert C et al. Cardiac resynchronization induces major structural and functional reverse remodeling in patients with New York Heart Association Class I/II Heart Failure. Circulation 2009;120:1845-6.
2. Ghio S, Freemantle N, Scelsi L, Serio A, Magrini G, Pasotti M et al. Long-term left ventricular reverse remodelling with cardiac resynchronization therapy: Results from the CARE-HF trial. Eur J Heart Fail 2009;11:480-8.
3. Di Biase L, Gasparini M, Lunati M, Santini M, Landolina M, Boriani G et al. Antiarrhythmic effect of reverse ventricular remodeling induced by cardiac resynchronization therapy: The InSync ICD (Implantable Cardioverter- Defibrillator) Italian Registry. J Am Coll Cardiol 2008;52:1442-9.
4. Markowitz SM, Lewen JM, Wiggenhorn CJ, Abraham WT, Stein KM, Iwai S et al. Relationship of reverse anatomical remodelling and ventricular arrhythmias after cardiac resynchronization. J Cardiovasc Electrophysiol 2009;20:293-8.
5. Turitto G, El-Sherif N. Cardiac resynchronization therapy: A review of proarrhythmic and antiarrhythmic mechanisms. Pacing Clin Electrophysiol 2007;30:115-22. (Pubitemid 46114937)
6. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L et al. Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase]. Eur Heart J 2006;27:1928-32. (Pubitemid 44297365)
7. Higgins SL, Hummel JD, Niazi IK, Giudici MC, Worley SJ, Saxon LA et al. Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. J Am Coll Cardiol 2003;42:1454-9. (Pubitemid 37267289)
8. Rivero-Ayerza M, Theuns DA, Garcia-Garcia HM, Boersma E, Simoons M, Jordaens LJ. Effects of cardiac resynchronization therapy on overall mortality and mode of death: A meta-analysis of randomized controlled trials. Eur Heart J 2006;27:2682-8. (Pubitemid 44729869)
9. Young JB, Abraham WT, Smith AL, Leon AR, Lieberman R, Wilkoff B et al. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: The MIRACLE ICD Trial. JAMA 2003;289: 2685-94. (Pubitemid 37430139)
10. Chalil S, Yousef ZR, Muyhaldeen SA, Smith RE, Jordan P, Gibbs CR et al. Pacing-induced increase in QT dispersion predicts sudden cardiac death following cardiac resynchronization therapy. J Am Coll Cardiol 2006;47:2486-92.
11. Kowey PR, Yan GX. Proarrhythmias and antiarrhythmias: Two sides of the same coin. Heart Rhythm 2005;2:957-9. (Pubitemid 41372283)
12. Di Diego JM, Belardinelli L, Antzelevitch C. Cisapride-induced transmural dispersion of repolarization and torsade de pointes in the canine left ventricular wedge preparation during epicardial stimulation. Circulation 2003;108:1027-33. (Pubitemid 37048236)
13. Medina-Ravell VA, Lankipalli RS, Yan G-X, Antzelevitch C, Medina-Malpica NA, Medina-Malpica OA et al. Effect of epicardial or biventricular pacing to prolong QT interval and increase transmural dispersion of repolarization: Does resynchronization therapy pose a risk for patients predisposed to long QT or torsade de pointes? Circulation 2003;107:740-6. (Pubitemid 36222603)
14. Combes N, Marijon E, Boveda S, Albenque JP. Electrical storm after CRT implantation treated by AV delay optimization. J Cardiovasc Electrophysiol 2010; 21:211-3.
15. van Huysduynen BH, Swenne CA, Bax JJ, Bleeker GB, Draisma HH, van Erven L et al. Dispersion of repolarization in cardiac resynchronization therapy. Heart Rhythm 2005;2:1286-93. (Pubitemid 43055410)
16. Bai R, Yang XY, Song Y, Lin L, Lu JG, Ching CK et al. Impact of left ventricular epicardial and biventricular pacing on ventricular repolarization in normal-heart individuals and patients with congestive heart failure. Europace 2006;8:1002-10.
17. Bortone A, Macia JC, Leclercq F, Pasquie JL. Monomorphic ventricular tachycardia induced by cardiac resynchronization therapy in patient with severe nonischemic dilated cardiomyopathy. Pacing Clin Electrophysiol 2006;29:327-30. (Pubitemid 43881410)
18. Shukla G, Chaudhry GM, Orlov M, Hoffmeister P, Haffajee C. Potential proarrhythmic effect of biventricular pacing: Fact or myth? Heart Rhythm 2005;2: 951-6. (Pubitemid 41372282)
19. Kantharia BK, Patel JA, Nagra BS, Ledley GS. Electrical storm of monomorphic ventricular tachycardia after a cardiac-resynchronization-therapy- defibrillator upgrade. Europace 2006;8:625-8. (Pubitemid 44295760)
20. Nowinski K, Gadler F, Jensen-Urstad M, Bergfeldt L. Transient proarrhythmic state following atrioventricular junction radiofrequency ablation: Pathophysiologic mechanisms and recommendations for management. Am J Med 2002;113:596-602. (Pubitemid 35385641)
21. Valzania C, Gadler F, Eriksson MJ, Olsson A, Boriani G, Braunschweig F. Electromechanical effects of cardiac resynchronization therapy during rest and stress in patients with heart failure. Eur J Heart Fail 2007;9:644-50. (Pubitemid 46702814)
22. Bax JJ, Ansalone G, Breithardt OA, Derumeaux G, Leclercq C, Schalij MJ et al. Echocardiographic evaluation of cardiac resynchronization therapy: Ready for routine clinical use? A critical appraisal. J Am Coll Cardiol 2004;44:1-9. (Pubitemid 38968446)
23. Lepeschkin E, Surawicz B. The measurement of the Q-T interval of the electrocardiogram. Circulation 1952;6:378-88.
24. Wecke L, Rubulis A, Lundahl G, Rosen MR, Bergfeldt L. Right ventricular pacing-induced electrophysiological remodeling in the human heart and its relationship to cardiac memory. Heart Rhythm 2007;4:1477-86. (Pubitemid 350187686)
25. Sahlén A, Rubulis A, Winter R, Jacobsen PH, Stahlberg M, Tornvall P et al. Cardiac fatigue in long-distance runners is associated with ventricular repolarization abnormalities. Heart Rhythm 2009;6:512-9.
26. Rubulis A, Jensen J, Lundahl G, Tapanainen J, Wecke L, Bergfeldt L. T vector and loop characteristics in coronary artery disease and during acute ischemia. Heart Rhythm 2004;1:317-25. (Pubitemid 39549762)
27. Pogwizd SM, McKenzie JP, Cain ME. Mechanisms underlying spontaneous and induced ventricular arrhythmias in patients with idiopathic dilated cardiomyopathy. Circulation 1998;98:2404-14. (Pubitemid 28549784)
28. Harada M, Osaka T, Yokoyama E, Takemoto Y, Ito A, Kodama I. Biventricular pacing has an advantage over left ventricular epicardial pacing alone to minimize proarrhythmic perturbation of repolarization. J Cardiovasc Electrophysiol 2006;17:151-6. (Pubitemid 43344865)
29. Roden DM. Long QT syndrome: Reduced repolarization reserve and the genetic link. J Intern Med 2006;259:59-69.
30. Kass DA. Pathobiology of cardiac dyssynchrony and resynchronization. Heart Rhythm 2009;6:1660-5.
31. Aiba T, Hesketh GG, Barth AS, Liu T, Daya S, Chakir K et al. Electrophysiological consequences of dyssynchronous heart failure and its restoration by resynchronization therapy. Circulation 2009;119:1220-30.
32. Leyva F, Foley PW. Is cardiac resynchronisation therapy proarrhythmic? Indian Pacing Electrophysiol J 2008;8:268-80.
33. Ghosh S, Rhee EK, Avari JN, Woodard PK, Rudy Y. Cardiac memory in patients with Wolff-Parkinson-White syndrome: Noninvasive imaging of activation and repolarization before and after catheter ablation. Circulation 2008; 118:907-15.
34. Van Huysduynen BH, Swenne CA, Draisma HH, Antoni ML, Van De Vooren H, Van DerWall EE et al. Validation of ECG indices of ventricular repolarization heterogeneity: A computer simulation study. J Cardiovasc Electrophysiol 2005;16: 1097-103.
35. Nowinski K, Jensen S, Lundahl G, Bergfeldt L. Changes in ventricular repolarization during percutaneous transluminal coronary angioplasty in humans assessed by QT interval, QT dispersion and T vector loop morphology. J Intern Med 2000;248:126-36. (Pubitemid 30603034)
36. Odenstedt J, Rubulis A, Grip L, Bergfeldt L. Distorted T-vector loop and increased heart rate are associated with ventricular fibrillation in a porcine ischemia-reperfusion model. J Electrocardiol 2009;42:267-73.
37. Padeletti L, Fantappie C, Perrotta L, Ricciardi G, Pieragnoli P, Chiostri M et al. Cardiac memory in humans: Vectocardiographic quantification in cardiac resynchronization therapy. Clin Res Cardiol 2011;100:51-6.
38. Nowinski K, Gadler F, Jensen-Urstad M, Bergfeldt L. Transient proarrhythmic state following atrioventricular junctional radiofrequency ablation. Pacing Clin Electrophysiol 2002;25:291-9. (Pubitemid 34274409)
39. Roden DM. Drug-induced prolongation of the QT interval. N Engl J Med 2004; 350:1013-22. (Pubitemid 38269278)
40. Malik M, Batchvarov VN. Measurement, interpretation and clinical potential of QT dispersion. J Am Coll Cardiol 2000;36:1749-66.
41. Stahlberg M, Kessels R, Linde C, Braunschweig F. Acute haemodynamic effects of increase in paced heart rate in heart failure patients recorded with an implantable haemodynamic monitor. Europace 2011;13:237-43.
42. Braunschweig F, Boriani G, Bauer A, Hatala R, Herrmann-Lingen C, Kautzner J et al. Management of patients receiving implantable cardiac defibrillator shocks: Recommendations for acute and long-term patient management. Europace 2010; 12:1673-90.